Eptifibatide Injection
Eptifibatide | C35H49N11O9S2 - PubChem
Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases | Pharmacological Reviews
Use of Cangrelor in a Contemporary Practice of STEMI Interventions
Point-of-Care Testing for Anticoagulation Monitoring in Neuroendovascular Procedures | American Journal of Neuroradiology
Antiplatelet Agents in Acute ST Elevation Myocardial Infarction - The American Journal of Medicine
Established antiplatelet substances. Thienopyridines such as... | Download Scientific Diagram
View Image
Clinical and economic studies of eptifibatide in coronary stenting | TCRM
Antiplatelet Drugs for Neurointerventions: Part 1 Clinical Pharmacology | SpringerLink
Antiplatelet therapies for the treatment of cardiovascular disease | Nature Reviews Drug Discovery
Clinical Pharmacology of Eptifibatide - ScienceDirect
P2Y12 Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity | Journal of the American Heart Association
Drug Therapy of Thromboembolic Disorders | Basicmedical Key
Use of Cangrelor in a Contemporary Practice of STEMI Interventions
References in Perioperative management of antiplatelet therapy - British Journal of Anaesthesia
Antiplatelet Drugs | Concise Medical Knowledge
Eptifibatide - an overview | ScienceDirect Topics
Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic - ScienceDirect
Antiplatelet Drugs - Hematology - Medbullets Step 1
